We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Modern Water Plc | LSE:MWG | London | Ordinary Share | GB00B1XF5X66 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.45 | 2.40 | 2.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/1/2018 10:08 | rns re gibraltar :0) | wynmck | |
30/1/2018 10:08 | 22 million contract yes 22 MILLION Do not fall off seat. This went from 6p to 35p+ on a spike once on no contract | dave4545 | |
12/1/2018 17:10 | I think it was the new director buying.hope I'm wrong and there's a leak! | gemlotte55 | |
12/1/2018 16:40 | Post 1740 Nobert Colon well worth reading link in full AT LEAST TWICE - My take is that FO is probably DEAD - For reasons (unspecified) not taken up by potential users - Anyone access to or close enough to the market to advise on reasons ? Link reposted as for some reason NC's link did not find article. If gut feel (mine) correct $64K question is "Will Modern Water survive" | pugugly | |
12/1/2018 15:16 | First sign of life in the last six months. 100k shares bought at 13,56, followed by a few speculative copy catfish. Just hope ? Or has there been a leak in the system? | scrutable | |
12/1/2018 14:12 | Bubbling along nicely now - news coming? Looks good value down here. | philjeans | |
04/1/2018 16:28 | Not big purchases today, some ramp b4 the inevitable no doubt | melodrama | |
04/1/2018 16:26 | That new Non exec didn't buy a bean on his appointment. One would have thought it was "Cricket" to do so , given his CV, but no | melodrama | |
04/1/2018 16:23 | "Live in hope, die in despair" or penniless in the case of MWG shareholders ;-) | argylerich | |
04/1/2018 16:10 | Thankfully a glimmer of interest today. I was hoping for a New Year Tip somewhere....a bit late for that surely! | skyship | |
21/12/2017 12:32 | Major rival Oasys selling their FO IP after sales dry up. | norbert colon | |
18/12/2017 15:22 | Chart looks good. Hope so Dave 😁 | gemlotte55 | |
18/12/2017 15:11 | Full offer to buy 8.5p is this one going to turn again more positive it's been a while ? | dave4545 | |
14/12/2017 08:57 | Sitting on the sidelines waiting to buy, that bloke sounds pretty impressive I have to say. Wonder if he will buy any! | melodrama | |
14/12/2017 08:48 | see they've appointed a non ex director, lets hope he can drive this forward | gemlotte55 | |
27/11/2017 14:00 | 4288 buys at 9.14p at 13.32pm and sells them for 8.82p at 13.49pm Honestly what are these people expecting to happen in 17 minutes in a quiet stock and with a £400 punt you need a big % gain to beat the mm's and commissions. Idiots everywhere | dave4545 | |
22/11/2017 11:11 | IMMUPHARMA (IMM) Potential blockbuster Lupuzor Phase III results due Q1 2018. Only other similar drug Benlysta was bought out from HGSi by GSK in 2012 for $3.6 billion for 50% stake valuing Benlysta around $7 billion (and IMM's Lupuzor appears to be safer and more efficaceous than Benlysta). $7 billion buyout of IMM gives £39.70 share price against current 97p, or 40+ bagger !!! Actual return could be even higher (£100+) because Lupuzor likely to be used in multiple block buster indications. IMM suggest - autoimmune diseases (e.g. rheumatoid arthritis, Sjogren's Syndrome, Crohn's Disease + Ulcerative Colitis, and Chronic Inflammatory Demyelinating Polyneuropathy [CIDP]), plus non-autoimmune diseases. It could therefore be several blockbusters in one. (An analyst note states they, "understand that a majority of Phase IIb patients showed resolution of the arthritis measure (four point score...)". Potential blockbuster Lupuzor has 'Fast Track' (guaranteed approval within 6 months) and 'SPA' status from US FDA, so could market launched in 2018. Tim McCarthy (IMM's Chairman) 14/3/2017: "There's going to be a fantastic return on investment for anybody who invests in ImmuPharma...This (Lupuzor) is going to be a multi-billion dollar drug, its as simple as that...This will absolutely be a multi-billion dollar drug." 4 min 40 sec. | top tips | |
13/11/2017 12:22 | They said that back in May. Final stages blah blah. They can easily borrow the money if they wanted to. Just game playing. | madmonkflin | |
13/11/2017 12:04 | So will take another year to finalise? Polluting the oceans they should be making this a priority!!! | joeblogg2 | |
13/11/2017 11:56 | New plant "in final stages" | norbert colon | |
13/11/2017 11:56 | New sewage plant "in final stages" | norbert colon | |
08/11/2017 10:58 | Added details to the header. | hottingup | |
08/11/2017 09:11 | Gb the old board came from the old public sector water companies and quite frankly were not up to the job of marketing innovative solutions. One of the big multinational engineers could do the job nicely. | argylerich | |
08/11/2017 08:31 | It would be a nice fit for Northumbrian who we're in Gibraltar with (if it ever gets the go Ahead) MW is a very small company in a very big pond, if you'll excuse the pun. NWL could open those doors for our technology? | gbenson1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions